Skip to main content
Caplight Logo









NovoBind Livestock Therapeutics Inc.

NovoBind Livestock Therapeutics Inc.

Private
Vancouver, British ColumbiaHealthcare & Life Scienceshttps://novobind.com

Last Round

Grant

Nov 1, 2021

Total Funding Raised

$1.08M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

NovoBind Livestock Therapeutics Inc. operates in Healthcare & Life Sciences and is based in Vancouver, British Columbia. Its latest recorded funding round was a Grant round in November 2021.

NovoBind Livestock Therapeutics Inc. is a biotechnology company that develops next-generation biologics to neutralize bacteria, viruses, and parasites that cause intestinal ailments in livestock, aquaculture, and pets.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting, Government Contracts

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

NovoBind Livestock Therapeutics Inc. Comparables

Compare NovoBind Livestock Therapeutics Inc. with similar companies based on industry and business-model similarity.

NovoBind Livestock Therapeutics Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Folium Science
83%
BiomEdit
79%
Animab
73%
Book a demo to see all comparables

For institutional investors. Book with your work email.

NovoBind Livestock Therapeutics Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantNov 1, 2021
GrantSep 1, 2020
Series AFeb 19, 2020
GrantJul 1, 2019
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Key People

Founding team and executive leadership

CPA CA Hamlet Abnousi

Co-Founder And CEO

Founding Team

For institutional investors. Book with your work email.

NovoBind Livestock Therapeutics Inc. Investors

Notable investors and investment history

NovoBind Livestock Therapeutics Inc. investors
InvestorRounds
Agriculture and Agri-Food CanadaGrant
Canada-BC Agri-Innovation ProgramGrant
National Research Council of CanadaGrant
Natural Products CanadaSeries A
Mindset Venture GroupSeries A
VANTEC Angel NetworkSeed
Seventure PartnersSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 20, 2026

    Monthly visitors increased 449% MoM, reaching 2.4K.

  • Nov 1, 2021

    $486K grant received from Agriculture and Agri-Food Canada.

Book a demo to see all signals

For institutional investors. Book with your work email.

NovoBind Livestock Therapeutics Inc. Filings

Explore SEC and related filing metadata, where available.

NovoBind Livestock Therapeutics Inc. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about NovoBind Livestock Therapeutics Inc.'s valuation, stock price, and market status.

Is NovoBind Livestock Therapeutics Inc. a public or private company?

NovoBind Livestock Therapeutics Inc. is a private company.

What is the current stock price of NovoBind Livestock Therapeutics Inc.?

NovoBind Livestock Therapeutics Inc. is a private company, so its shares have no public market price. Caplight tracks NovoBind Livestock Therapeutics Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is NovoBind Livestock Therapeutics Inc. worth (valuation)?

Valuation information for NovoBind Livestock Therapeutics Inc. is not publicly available.

Can I buy NovoBind Livestock Therapeutics Inc. stock?

NovoBind Livestock Therapeutics Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was NovoBind Livestock Therapeutics Inc.'s last funding round?

NovoBind Livestock Therapeutics Inc.'s most recent funding round was Grant on November 1, 2021.

Who are the main investors in NovoBind Livestock Therapeutics Inc.?

Key investors in NovoBind Livestock Therapeutics Inc. include Agriculture and Agri-Food Canada, Canada-BC Agri-Innovation Program, National Research Council of Canada, Natural Products Canada, Mindset Venture Group.

Will NovoBind Livestock Therapeutics Inc. IPO soon?

No public IPO plans have been announced for NovoBind Livestock Therapeutics Inc..

How can I track NovoBind Livestock Therapeutics Inc. secondary market activity?

Caplight tracks bids, offers, and trades in NovoBind Livestock Therapeutics Inc.'s shares on secondary markets.

Firmographic Details

HeadquartersVancouver, British Columbia
Employee Range7
Year Founded2012
Last FundingNov 1, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?